April 30th 2024
Pemivibart will act as an additional preventive option for COVID-19 among moderately-to-severely immunocompromised adult and adolescent patients, who are disproportionally impacted by the condition.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
MJH Life Sciences COVID-19 Coalition to Host Live Webinar on Dual Flu, COVID-19 Threats
September 10th 2020In a partnership with top health care experts, MJH Life Sciences™ COVID-19 Coalition will host its inaugural event, "Battling Dual Threats: Flu and COVID-19 Converge" on Tuesday, September 15, at 6 p.m. EDT.